Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89


Sdc1 negatively modulates carcinoma cell motility and invasion.

Ishikawa T, Kramer RH.

Exp Cell Res. 2010 Apr 1;316(6):951-65. doi: 10.1016/j.yexcr.2009.12.013. Epub 2009 Dec 28.


Syndecan-1 and -4 differentially regulate oncogenic K-ras dependent cell invasion into collagen through α2β1 integrin and MT1-MMP.

Vuoriluoto K, Högnäs G, Meller P, Lehti K, Ivaska J.

Matrix Biol. 2011 Apr;30(3):207-17. doi: 10.1016/j.matbio.2011.03.003. Epub 2011 Mar 23.


Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains.

Yang N, Friedl A.

PLoS One. 2016 Feb 24;11(2):e0150132. doi: 10.1371/journal.pone.0150132. eCollection 2016.


G alpha 12 inhibits alpha2 beta1 integrin-mediated Madin-Darby canine kidney cell attachment and migration on collagen-I and blocks tubulogenesis.

Kong T, Xu D, Yu W, Takakura A, Boucher I, Tran M, Kreidberg JA, Shah J, Zhou J, Denker BM.

Mol Biol Cell. 2009 Nov;20(21):4596-610. doi: 10.1091/mbc.E09-03-0220. Epub 2009 Sep 23.


Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1.

Zhou H, Kramer RH.

J Biol Chem. 2005 Mar 18;280(11):10624-35. Epub 2004 Dec 17.


Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation.

Beauvais DM, Rapraeger AC.

J Cell Sci. 2010 Nov 1;123(Pt 21):3796-807. doi: 10.1242/jcs.067645.


Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen.

Vuoriluoto K, Jokinen J, Kallio K, Salmivirta M, Heino J, Ivaska J.

Exp Cell Res. 2008 Nov 1;314(18):3369-81. doi: 10.1016/j.yexcr.2008.07.005. Epub 2008 Jul 15.


Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility.

Yang N, Mosher R, Seo S, Beebe D, Friedl A.

Am J Pathol. 2011 Jan;178(1):325-35. doi: 10.1016/j.ajpath.2010.11.039. Epub 2010 Dec 23.


Syndecan-1 regulates cell migration and fibronectin fibril assembly.

Stepp MA, Daley WP, Bernstein AM, Pal-Ghosh S, Tadvalkar G, Shashurin A, Palsen S, Jurjus RA, Larsen M.

Exp Cell Res. 2010 Aug 15;316(14):2322-39. doi: 10.1016/j.yexcr.2010.05.020. Epub 2010 May 24.


Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.

Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, Dreier R, Kelsch R, Fischgräbe J, Smollich M, Rossi LH, Sibrowski W, Wülfing P, Kiesel L, Yip GW, Götte M.

Carcinogenesis. 2009 Mar;30(3):397-407. doi: 10.1093/carcin/bgp001. Epub 2009 Jan 6.


Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of alpha2beta1 integrin.

Zhang ZG, Bothe I, Hirche F, Zweers M, Gullberg D, Pfitzer G, Krieg T, Eckes B, Aumailley M.

J Cell Sci. 2006 May 1;119(Pt 9):1886-95.


Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.

Yamazaki D, Kurisu S, Takenawa T.

Oncogene. 2009 Apr 2;28(13):1570-83. doi: 10.1038/onc.2009.2. Epub 2009 Feb 23.


Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice.

Floer M, Götte M, Wild MK, Heidemann J, Gassar ES, Domschke W, Kiesel L, Luegering A, Kucharzik T.

Am J Pathol. 2010 Jan;176(1):146-57. doi: 10.2353/ajpath.2010.080639. Epub 2009 Dec 11.


Transmembrane and extracellular domains of syndecan-1 have distinct functions in regulating lung epithelial migration and adhesion.

Altemeier WA, Schlesinger SY, Buell CA, Brauer R, Rapraeger AC, Parks WC, Chen P.

J Biol Chem. 2012 Oct 12;287(42):34927-35. doi: 10.1074/jbc.M112.376814. Epub 2012 Aug 30.


Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation.

Hassan H, Greve B, Pavao MS, Kiesel L, Ibrahim SA, Götte M.

FEBS J. 2013 May;280(10):2216-27. doi: 10.1111/febs.12111. Epub 2013 Jan 31.


Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism.

Ibrahim SA, Yip GW, Stock C, Pan JW, Neubauer C, Poeter M, Pupjalis D, Koo CY, Kelsch R, Schüle R, Rescher U, Kiesel L, Götte M.

Int J Cancer. 2012 Sep 15;131(6):E884-96. doi: 10.1002/ijc.27629. Epub 2012 May 30.


Cytoplasmic domain interactions of syndecan-1 and syndecan-4 with α6β4 integrin mediate human epidermal growth factor receptor (HER1 and HER2)-dependent motility and survival.

Wang H, Jin H, Beauvais DM, Rapraeger AC.

J Biol Chem. 2014 Oct 31;289(44):30318-32. doi: 10.1074/jbc.M114.586438. Epub 2014 Sep 8.

Supplemental Content

Support Center